Food Standards; General Principles and Food Standards Modernization; Reopening of the Comment Period, 10107-10110 [2020-03437]
Download as PDF
Federal Register / Vol. 85, No. 35 / Friday, February 21, 2020 / Proposed Rules
FTC Rule 4.10(a)(2), 16 CFR 4.10(a)(2)—
including in particular competitively
sensitive information such as costs,
sales statistics, inventories, formulas,
patterns, devices, manufacturing
processes, or customer names.
Comments containing material for
which confidential treatment is
requested must be filed in paper form,
must be clearly labeled ‘‘Confidential,’’
and must comply with FTC Rule 4.9(c).
In particular, the written request for
confidential treatment that accompanies
the comment must include the factual
and legal basis for the request, and must
identify the specific portions of the
comment to be withheld from the public
record. See FTC Rule 4.9(c). Your
comment will be kept confidential only
if the General Counsel grants your
request in accordance with the law and
the public interest. Once your comment
has been posted publicly at
www.regulations.gov—as legally
required by FTC Rule 4.9(b)—we cannot
redact or remove your comment, unless
you submit a confidentiality request that
meets the requirements for such
treatment under FTC Rule 4.9(c), and
the General Counsel grants that request.
Visit the FTC website to read this
request for comment and the news
release describing it. The FTC Act and
other laws that the Commission
administers permit the collection of
public comments to consider and use in
this proceeding as appropriate. The
Commission will consider all timely
and responsive public comments that it
receives on or before April 21, 2020. For
information on the Commission’s
privacy policy, including routine uses
permitted by the Privacy Act, see
https://www.ftc.gov/site-information/
privacy-policy.
By direction of the Commission.
April J. Tabor,
Acting Secretary.
[FR Doc. 2020–03447 Filed 2–20–20; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
18 CFR Part 35
khammond on DSKJM1Z7X2PROD with PROPOSALS
[Docket No. AD20–6–000]
Request for Technical Conference and
Petition for Rulemaking: Energy
Trading Institute
Federal Energy Regulatory
Commission, Department of Energy.
ACTION: Notice of request for technical
conference and petition for rulemaking.
AGENCY:
VerDate Sep<11>2014
16:42 Feb 20, 2020
Jkt 250001
The Federal Energy
Regulatory Commission has received a
petition from the Energy Trading
Institute requesting that the Commission
hold a technical conference and conduct
a rulemaking to update the requirements
adopted in Order No. 741 and
Commission’s regulations addressing
credit and risk management in the
markets operated by Independent
System Operators and Regional
Transmission Organizations.
DATES: Comments are due March 12,
2020.
SUMMARY:
Comments, identified by
docket number, may be filed in the
following ways:
• Electronic Filing through https://
www.ferc.gov. Documents created
electronically using word processing
software should be filed in native
applications or print-to-PDF format and
not in a scanned format.
• Mail/Hand Delivery: Those unable
to file electronically may mail or handdeliver comments to: Federal Energy
Regulatory Commission, Secretary of the
Commission, 888 First Street NE,
Washington, DC 20426.
FOR FURTHER INFORMATION CONTACT:
Tina Ham (Legal Information), Office of
the General Counsel, Federal Energy
Regulatory Commission, 888 First
Street NE, Washington, DC 20426,
Telephone: (202) 502–8887,
Tina.Ham@ferc.gov.
Michael Hill (Policy Information), Office
of Energy Policy and Innovation,
Federal Energy Regulatory
Commission, 888 First Street NE,
Washington, DC 20426, Telephone:
(202) 502–8703, Michael.Hill@
ferc.gov.
James Burchill (Policy Information),
Office of Energy Policy and
Innovation, Federal Energy Regulatory
Commission, 888 First Street NE,
Washington, DC 20426, Telephone:
(202) 502–6144, James.Burchill@
ferc.gov.
Anne Marie Hirschberger (Legal
Information), Office of the General
Counsel, Federal Energy Regulatory
Commission, 888 First Street NE,
Washington, DC 20426, Telephone:
(202) 502–8387,
AnneMarie.Hirschberger@ferc.gov.
SUPPLEMENTARY INFORMATION: On
December 16, 2019, the Energy Trading
Institute filed in the above-captioned
docket a petition requesting that the
Commission hold a technical conference
and conduct a rulemaking to update the
requirements adopted in Order No. 741 1
ADDRESSES:
1 Credit Reforms in Organized Wholesale Electric
Markets, Order No. 741, 133 FERC ¶ 61,060 (2010)
(Order No. 741), order on reh’g, Order No. 741–A,
PO 00000
Frm 00012
Fmt 4702
Sfmt 4702
10107
and section 35.47 of the Commission’s
regulations 2 addressing credit and risk
management in the markets operated by
Independent System Operators and
Regional Transmission Organizations.
Dated: February 11, 2020.
Kimberly D. Bose,
Secretary.
[FR Doc. 2020–03272 Filed 2–20–20; 8:45 am]
BILLING CODE 6717–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 130
[Docket No. FDA–1995–N–0062 (Formerly
1995N–0294)]
RIN 0910–AC54
Food Standards; General Principles
and Food Standards Modernization;
Reopening of the Comment Period
AGENCY:
Food and Drug Administration,
HHS.
Proposed rule; reopening of the
comment period.
ACTION:
The Food and Drug
Administration (FDA or we) is
reopening the comment period for the
proposed rule, published in the Federal
Register of May 20, 2005, entitled ‘‘Food
Standards; General Principles and Food
Standards Modernization,’’ to establish
a set of general principles for food
standards for FDA to use when
considering whether to establish, revise,
or eliminate a food standard. The
proposed rule was issued jointly with
the United States Department of
Agriculture (USDA) and, while FDA
will continue to engage with USDA
regarding the proposed rule, we are
reopening the comment period to
receive new data, information, or further
comments only on FDA-specific aspects
of the proposed rule, including FDA’s
13 general principles.
DATES: We are reopening the comment
period on the proposed rule that
published in the Federal Register of
May 20, 2005 (70 FR 29214). Submit
either electronic or written comments
by April 21, 2020.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before April 21,
2020. The https://www.regulations.gov
SUMMARY:
134 FERC ¶ 61,126 (2011), reh’g denied, Order No.
741–B, 135 FERC ¶ 61,242 (2011).
2 18 CFR 35.47 (2019).
E:\FR\FM\21FEP1.SGM
21FEP1
10108
Federal Register / Vol. 85, No. 35 / Friday, February 21, 2020 / Proposed Rules
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of April 21, 2020. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
khammond on DSKJM1Z7X2PROD with PROPOSALS
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
1995–N–0062 (formerly 1995N–0294)
for ‘‘General Principles and Food
Standards Modernization; Reopening of
the Comment Period.’’ Received
comments, those filed in a timely
manner (see ADDRESSES), will be placed
in the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
VerDate Sep<11>2014
16:42 Feb 20, 2020
Jkt 250001
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ FDA
will review this copy, including the
claimed confidential information, in its
consideration of comments. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Rumana Yasmeen, Center for Food
Safety and Applied Nutrition, Food and
Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240–402–6060.
SUPPLEMENTARY INFORMATION:
I. Background on the Proposed Rule
In the Federal Register of May 20,
2005 (70 FR 29214), FDA and USDA
jointly issued a proposed rule entitled
‘‘Food Standards; General Principles
and Food Standards Modernization,’’ as
a first step in instituting a process to
modernize FDA definitions and
standards of identity (and standards of
quality and fill of container) consistent
with section 401 of the Federal Food,
PO 00000
Frm 00013
Fmt 4702
Sfmt 4702
Drug, and Cosmetic Act (21 U.S.C. 341),
and USDA’s definitions and standards
of identity or composition under the
Federal Meat Inspection Act and the
Poultry Products Inspection Act (21
U.S.C. 607(c) and 457(b)) (and standards
of fill of container). The proposed rule,
if finalized, would establish general
principles that FDA and USDA would
consider when determining whether to
establish, revise, or eliminate a food
standard.
Although the general principles were
mostly consistent between FDA and
USDA, a few principles were not
identical. Because FDA and USDA
regulate different products under
different statutory authorities, some
principles were developed to reflect
specific FDA or USDA regulatory needs
and perspectives. FDA and USDA stated
that adherence to principles identified
in the proposed rule would result in
standards that would (1) better promote
honesty and fair dealing in the interest
of consumers and protect the public; (2)
allow for technological advances in food
production; (3) be consistent with
international food standards to the
extent feasible; and (4) be clear, simple,
and easy to use for both manufacturers
and the agencies that enforce
compliance with the standards.
The Preliminary Regulatory Impact
Analysis (PRIA) of the proposed rule
anticipated that the associated social
costs of finalizing both FDA and USDA
principles would be small, however
would likely yield substantial benefits.
The PRIA noted that:
Standards that contain unnecessary
elements or that fail to provide flexibility in
terms of allowable food technology, may
generate unnecessary production costs, and
impede technological innovation in the food
industry. Such standards may also serve as
effective barriers to competition, thereby
raising product prices and transferring
resources from consumers to producers.
Finally, some standards may be inconsistent
with international standards, which may
impede international trade. Impeding
international trade may also restrict
competition and lead to higher product
prices.
The PRIA stated that applying the
principles set forth in the proposed rule
could help address these issues and that
the benefits of establishing the proposed
principles outweighed the costs.
Interested persons were originally
given until August 18, 2005, to
comment on these proposed general
principles and to provide additional
information as described in the Request
for Comments section of the proposed
rule. While comments received were
generally supportive, FDA and USDA
did not finalize the proposed rule due
E:\FR\FM\21FEP1.SGM
21FEP1
Federal Register / Vol. 85, No. 35 / Friday, February 21, 2020 / Proposed Rules
khammond on DSKJM1Z7X2PROD with PROPOSALS
to resource constraints and competing
priorities.
II. FDA Principles in the Proposed Rule
In the proposed rule, FDA proposed a
set of 13 general principles we would
consider when establishing, revising, or
eliminating a food standard (see 70 FR
29214 at 29234 to 29235 (proposed 21
CFR 130.5(b)). The first four general
principles stated the purpose or
function of a food standard and were the
most fundamental principles addressing
consumer economic protection.
Therefore, if a food standard is
inconsistent with any one of these four
principles, we would consider
eliminating it. The proposed rule also
would revise or establish a new food
standard if it was consistent with the
full set of 13 principles:
1. Promotes honesty and fair dealing
in the interest of consumers.
2. Describes the basic nature of the
food to ensure that consumers are not
misled by the name of the food and to
meet consumers’ expectations of
product characteristics and uniformity.
3. Reflects the essential characteristics
of the food—or those that define or
distinguish a food or describe the
distinctive properties of a food and that
may contribute to achieving the food’s
basic nature or may reflect relevant
consumer expectations of a food
product.
4. Ensures food does not appear to be
better or of a greater value than it is.
May be used as a vehicle to improve the
overall nutritional quality of the food
supply.
5. Contains clear and easily
understood requirements to facilitate
compliance by food manufacturers.
6. Permits maximum flexibility in the
technology used to prepare the food
provided the technology does not alter
the basic nature or essential
characteristics, or adversely affect the
nutritional quality or safety, of the food.
Provides for any suitable, alternative
manufacturing process that
accomplishes the desired effect, and
describes ingredients as broadly and
generically as feasible.
7. Harmonizes with international food
standards to the extent feasible.
8. Is simple, easy to use, and
consistent among all food standards.
Includes only those elements that are
necessary to define the basic nature and
essential characteristics of a particular
food, without unnecessary details.
9. Allows for variations in the
physical attributes of the food. Where
necessary to provide for specific
variations in the physical attributes of a
food within the standard, variations are
consolidated into a single food standard.
VerDate Sep<11>2014
16:42 Feb 20, 2020
Jkt 250001
10. Incorporates general requirements
that pertain to multiple food standards
of a commodity group into general
regulatory provisions that address the
commodity group whenever possible.
11. Considers other relevant
regulations. Any specific requirements
for foods intended for further
manufacturing are incorporated within
the reference standard rather than
provided as a separate standard.
12. Provides terms that can be used to
name a food and allows terms to be used
in any order that is not misleading to
consumers.
13. Names of ingredients and
functional use categories in a food
standard should be consistent with
other food standards and relevant
regulations in this chapter, and, when
appropriate, incorporate current
scientific nomenclature.
III. FDA’s Current Food Standards
Modernization Efforts
Since publication of the proposed
rule, FDA announced our Nutrition
Innovation Strategy (NIS) with the goal
of helping to reduce preventable death
and disease related to poor nutrition.
The NIS focuses on, among other things,
providing incentives for food
manufacturers to produce products that
have more healthful attributes. Under
the NIS, FDA is seeking to modernize
food standards in a manner that will
achieve three primary goals: (1) Protect
consumers against economic
adulteration; (2) maintain the basic
nature, essential characteristics, and
nutritional integrity of food; and (3)
promote industry innovation and
provide flexibility to encourage
manufacturers to produce more
healthful foods.
In July 2018, FDA held a public
meeting on the NIS.1 At the meeting, we
led a breakout session to discuss our
food standards modernization goals and,
among other things, to learn from
stakeholders what FDA should be aware
of when reviewing our food standard
regulations and exploring how to
modernize. At this public meeting, and
in comments submitted to the public
meeting docket, stakeholders expressed
general support for FDA continuing its
work with USDA to finalize the
proposed rule. However, stakeholders
also shared that, given the time that has
passed since its publication, we should
reopen the comment period to allow the
public the opportunity to provide data
1 For more information, please visit FDA’s
website at: https://www.fda.gov/food/workshopsmeetings-webinars-food-and-dietary-supplements/
public-meeting-discuss-fdas-nutrition-innovationstrategy-07262018-07262018 or see the public
docket FDA–2018–N–2381.
PO 00000
Frm 00014
Fmt 4702
Sfmt 4702
10109
and information on changes that have
occurred in manufacturing, food
technology, market trends, and nutrition
science that FDA should consider when
determining next steps for the proposed
rule.
While FDA intends to work with
USDA if we pursue finalization of the
proposed rule, for purposes of this
notice we are only interested in
comments, data, and information on
FDA-specific aspects of the proposed
rule, including the 13 general principles
listed above.
IV. Additional Issues for Consideration
In response to stakeholder comments
and to inform our decision regarding
whether to proceed with finalizing the
proposed rule, we seek new information
and public comment on how we could
create general principles for establishing
new food standards and for revising or
eliminating existing food standards.
While FDA and USDA jointly issued the
proposed rule, we are only seeking
comments on the FDA-specific aspects
of the proposal. We encourage
comments to be as specific as possible
and, when possible, to provide data and
information for FDA to consider.
While the public may comment on
any FDA aspects of the proposed rule,
we are particularly interested in
comments on the following questions:
1. Should FDA finalize the proposed
rule? Why or why not?
2. Are there general FDA principles
that should be added, eliminated,
revised, or retained?
a. What is the specific principle?
b. Why should the principle be added,
eliminated, revised, or retained?
c. Are there specific product examples
that illustrate why a principle should be
added, eliminated, revised, or retained?
3. What specific revisions should FDA
make to the proposed rule’s principles
or framework to better reflect our
modernization goals of:
a. Protecting consumers against
economic adulteration?
b. Ensuring standardized foods
continue to meet consumer
expectations?
c. Maintaining the basic nature,
essential characteristics, and nutritional
integrity of food?
d. Promoting industry innovation?
e. Providing flexibility to produce
more healthful foods?
f. Facilitating additional flexibility
across all or broad categories of
standardized foods?
4. How should FDA weigh the general
principles?
a. The proposed rule stated that the
first four principles were the most
fundamental to addressing consumer
E:\FR\FM\21FEP1.SGM
21FEP1
10110
Federal Register / Vol. 85, No. 35 / Friday, February 21, 2020 / Proposed Rules
economic protection and therefore, FDA
would consider eliminating a food
standard if it is inconsistent with any of
these four principles.
i. Please explain whether you agree
with this framework.
ii. If you do not agree, what principles
should FDA consider when deciding
whether to eliminate a food standard?
b. The proposed rule explained that
FDA would consider revising or
establishing a new food standard only if
it was consistent with all 13 principles.
i. Please explain whether you agree
with this framework.
ii. If you do not agree, what principles
should FDA consider when deciding
whether to revise or establish a new
food standard?
5. What explanation is needed to
provide more clarity, certainty, or
context regarding:
a. The rationale for the principles?
b. How FDA will consider the
principles when evaluating whether to
eliminate, revise, or establish a new
food standard?
c. How stakeholders should use the
principles to inform the preparation of
petitions requesting that FDA eliminate,
revise, or establish a new food standard?
6. What additional information
should FDA consider when evaluating
the costs, benefits, and estimates of the
annual reporting burden of the proposed
rule?
Dated: February 13, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020–03437 Filed 2–20–20; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Electronic Submissions
Food and Drug Administration
21 CFR Part 866
[Docket No. FDA–2019–N–5192]
Microbiology Devices; Reclassification
of Human Immunodeficiency Virus
Serological Diagnostic and
Supplemental Tests and Human
Immunodeficiency Virus Nucleic Acid
Diagnostic and Supplemental Tests
khammond on DSKJM1Z7X2PROD with PROPOSALS
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Proposed amendment; proposed
order.
The Food and Drug
Administration (FDA or the Agency) is
proposing to reclassify certain human
immunodeficiency virus (HIV)
serological diagnostic and supplemental
SUMMARY:
VerDate Sep<11>2014
16:42 Feb 20, 2020
Jkt 250001
tests and HIV nucleic acid (NAT)
diagnostic and supplemental tests,
postamendments class III devices with
the product code MZF, into class II
(special controls), subject to premarket
notification. FDA is also proposing new
device classification regulations along
with special controls that the Agency
believes are necessary to provide a
reasonable assurance of safety and
effectiveness for these devices. FDA is
proposing this reclassification on its
own initiative. If finalized, this order
will reclassify these types of devices
from class III (premarket approval) to
class II (special controls) and reduce the
regulatory burdens associated with
these devices, as these types of devices
will no longer be required to submit a
premarket approval application (PMA)
but can instead submit a premarket
notification (510(k)) and receive
clearance before marketing their device.
DATES: Submit either electronic or
written comments by April 21, 2020.
Please see section XI of this document
for the proposed effective date when the
new requirements apply and for the
proposed effective date of a final order
based on this proposed order.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before April 21,
2020. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of April 21, 2020. Comments
received by mail/hand delivery/courier
(for written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
PO 00000
Frm 00015
Fmt 4702
Sfmt 4702
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed below (see ‘‘Written/
Paper Submissions’’ and
‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–N–5192 for ‘‘Microbiology
Devices; Reclassification of human
immunodeficiency virus serological
diagnostic and supplemental tests and
human immunodeficiency virus nucleic
acid diagnostic and supplemental tests’’.
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
E:\FR\FM\21FEP1.SGM
21FEP1
Agencies
[Federal Register Volume 85, Number 35 (Friday, February 21, 2020)]
[Proposed Rules]
[Pages 10107-10110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03437]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 130
[Docket No. FDA-1995-N-0062 (Formerly 1995N-0294)]
RIN 0910-AC54
Food Standards; General Principles and Food Standards
Modernization; Reopening of the Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Proposed rule; reopening of the comment period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is reopening the
comment period for the proposed rule, published in the Federal Register
of May 20, 2005, entitled ``Food Standards; General Principles and Food
Standards Modernization,'' to establish a set of general principles for
food standards for FDA to use when considering whether to establish,
revise, or eliminate a food standard. The proposed rule was issued
jointly with the United States Department of Agriculture (USDA) and,
while FDA will continue to engage with USDA regarding the proposed
rule, we are reopening the comment period to receive new data,
information, or further comments only on FDA-specific aspects of the
proposed rule, including FDA's 13 general principles.
DATES: We are reopening the comment period on the proposed rule that
published in the Federal Register of May 20, 2005 (70 FR 29214). Submit
either electronic or written comments by April 21, 2020.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before April 21, 2020. The https://www.regulations.gov
[[Page 10108]]
electronic filing system will accept comments until 11:59 p.m. Eastern
Time at the end of April 21, 2020. Comments received by mail/hand
delivery/courier (for written/paper submissions) will be considered
timely if they are postmarked or the delivery service acceptance
receipt is on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-1995-N-0062 (formerly 1995N-0294) for ``General Principles and Food
Standards Modernization; Reopening of the Comment Period.'' Received
comments, those filed in a timely manner (see ADDRESSES), will be
placed in the docket and, except for those submitted as ``Confidential
Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday.
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' FDA will review
this copy, including the claimed confidential information, in its
consideration of comments. The second copy, which will have the claimed
confidential information redacted/blacked out, will be available for
public viewing and posted on https://www.regulations.gov. Submit both
copies to the Dockets Management Staff. If you do not wish your name
and contact information to be made publicly available, you can provide
this information on the cover sheet and not in the body of your
comments and you must identify this information as ``confidential.''
Any information marked as ``confidential'' will not be disclosed except
in accordance with 21 CFR 10.20 and other applicable disclosure law.
For more information about FDA's posting of comments to public dockets,
see 80 FR 56469, September 18, 2015, or access the information at:
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Rumana Yasmeen, Center for Food Safety
and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr.,
College Park, MD 20740, 240-402-6060.
SUPPLEMENTARY INFORMATION:
I. Background on the Proposed Rule
In the Federal Register of May 20, 2005 (70 FR 29214), FDA and USDA
jointly issued a proposed rule entitled ``Food Standards; General
Principles and Food Standards Modernization,'' as a first step in
instituting a process to modernize FDA definitions and standards of
identity (and standards of quality and fill of container) consistent
with section 401 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
341), and USDA's definitions and standards of identity or composition
under the Federal Meat Inspection Act and the Poultry Products
Inspection Act (21 U.S.C. 607(c) and 457(b)) (and standards of fill of
container). The proposed rule, if finalized, would establish general
principles that FDA and USDA would consider when determining whether to
establish, revise, or eliminate a food standard.
Although the general principles were mostly consistent between FDA
and USDA, a few principles were not identical. Because FDA and USDA
regulate different products under different statutory authorities, some
principles were developed to reflect specific FDA or USDA regulatory
needs and perspectives. FDA and USDA stated that adherence to
principles identified in the proposed rule would result in standards
that would (1) better promote honesty and fair dealing in the interest
of consumers and protect the public; (2) allow for technological
advances in food production; (3) be consistent with international food
standards to the extent feasible; and (4) be clear, simple, and easy to
use for both manufacturers and the agencies that enforce compliance
with the standards.
The Preliminary Regulatory Impact Analysis (PRIA) of the proposed
rule anticipated that the associated social costs of finalizing both
FDA and USDA principles would be small, however would likely yield
substantial benefits. The PRIA noted that:
Standards that contain unnecessary elements or that fail to
provide flexibility in terms of allowable food technology, may
generate unnecessary production costs, and impede technological
innovation in the food industry. Such standards may also serve as
effective barriers to competition, thereby raising product prices
and transferring resources from consumers to producers. Finally,
some standards may be inconsistent with international standards,
which may impede international trade. Impeding international trade
may also restrict competition and lead to higher product prices.
The PRIA stated that applying the principles set forth in the
proposed rule could help address these issues and that the benefits of
establishing the proposed principles outweighed the costs.
Interested persons were originally given until August 18, 2005, to
comment on these proposed general principles and to provide additional
information as described in the Request for Comments section of the
proposed rule. While comments received were generally supportive, FDA
and USDA did not finalize the proposed rule due
[[Page 10109]]
to resource constraints and competing priorities.
II. FDA Principles in the Proposed Rule
In the proposed rule, FDA proposed a set of 13 general principles
we would consider when establishing, revising, or eliminating a food
standard (see 70 FR 29214 at 29234 to 29235 (proposed 21 CFR 130.5(b)).
The first four general principles stated the purpose or function of a
food standard and were the most fundamental principles addressing
consumer economic protection. Therefore, if a food standard is
inconsistent with any one of these four principles, we would consider
eliminating it. The proposed rule also would revise or establish a new
food standard if it was consistent with the full set of 13 principles:
1. Promotes honesty and fair dealing in the interest of consumers.
2. Describes the basic nature of the food to ensure that consumers
are not misled by the name of the food and to meet consumers'
expectations of product characteristics and uniformity.
3. Reflects the essential characteristics of the food--or those
that define or distinguish a food or describe the distinctive
properties of a food and that may contribute to achieving the food's
basic nature or may reflect relevant consumer expectations of a food
product.
4. Ensures food does not appear to be better or of a greater value
than it is. May be used as a vehicle to improve the overall nutritional
quality of the food supply.
5. Contains clear and easily understood requirements to facilitate
compliance by food manufacturers.
6. Permits maximum flexibility in the technology used to prepare
the food provided the technology does not alter the basic nature or
essential characteristics, or adversely affect the nutritional quality
or safety, of the food. Provides for any suitable, alternative
manufacturing process that accomplishes the desired effect, and
describes ingredients as broadly and generically as feasible.
7. Harmonizes with international food standards to the extent
feasible.
8. Is simple, easy to use, and consistent among all food standards.
Includes only those elements that are necessary to define the basic
nature and essential characteristics of a particular food, without
unnecessary details.
9. Allows for variations in the physical attributes of the food.
Where necessary to provide for specific variations in the physical
attributes of a food within the standard, variations are consolidated
into a single food standard.
10. Incorporates general requirements that pertain to multiple food
standards of a commodity group into general regulatory provisions that
address the commodity group whenever possible.
11. Considers other relevant regulations. Any specific requirements
for foods intended for further manufacturing are incorporated within
the reference standard rather than provided as a separate standard.
12. Provides terms that can be used to name a food and allows terms
to be used in any order that is not misleading to consumers.
13. Names of ingredients and functional use categories in a food
standard should be consistent with other food standards and relevant
regulations in this chapter, and, when appropriate, incorporate current
scientific nomenclature.
III. FDA's Current Food Standards Modernization Efforts
Since publication of the proposed rule, FDA announced our Nutrition
Innovation Strategy (NIS) with the goal of helping to reduce
preventable death and disease related to poor nutrition. The NIS
focuses on, among other things, providing incentives for food
manufacturers to produce products that have more healthful attributes.
Under the NIS, FDA is seeking to modernize food standards in a manner
that will achieve three primary goals: (1) Protect consumers against
economic adulteration; (2) maintain the basic nature, essential
characteristics, and nutritional integrity of food; and (3) promote
industry innovation and provide flexibility to encourage manufacturers
to produce more healthful foods.
In July 2018, FDA held a public meeting on the NIS.\1\ At the
meeting, we led a breakout session to discuss our food standards
modernization goals and, among other things, to learn from stakeholders
what FDA should be aware of when reviewing our food standard
regulations and exploring how to modernize. At this public meeting, and
in comments submitted to the public meeting docket, stakeholders
expressed general support for FDA continuing its work with USDA to
finalize the proposed rule. However, stakeholders also shared that,
given the time that has passed since its publication, we should reopen
the comment period to allow the public the opportunity to provide data
and information on changes that have occurred in manufacturing, food
technology, market trends, and nutrition science that FDA should
consider when determining next steps for the proposed rule.
---------------------------------------------------------------------------
\1\ For more information, please visit FDA's website at: https://www.fda.gov/food/workshops-meetings-webinars-food-and-dietary-supplements/public-meeting-discuss-fdas-nutrition-innovation-strategy-07262018-07262018 or see the public docket FDA-2018-N-2381.
---------------------------------------------------------------------------
While FDA intends to work with USDA if we pursue finalization of
the proposed rule, for purposes of this notice we are only interested
in comments, data, and information on FDA-specific aspects of the
proposed rule, including the 13 general principles listed above.
IV. Additional Issues for Consideration
In response to stakeholder comments and to inform our decision
regarding whether to proceed with finalizing the proposed rule, we seek
new information and public comment on how we could create general
principles for establishing new food standards and for revising or
eliminating existing food standards. While FDA and USDA jointly issued
the proposed rule, we are only seeking comments on the FDA-specific
aspects of the proposal. We encourage comments to be as specific as
possible and, when possible, to provide data and information for FDA to
consider.
While the public may comment on any FDA aspects of the proposed
rule, we are particularly interested in comments on the following
questions:
1. Should FDA finalize the proposed rule? Why or why not?
2. Are there general FDA principles that should be added,
eliminated, revised, or retained?
a. What is the specific principle?
b. Why should the principle be added, eliminated, revised, or
retained?
c. Are there specific product examples that illustrate why a
principle should be added, eliminated, revised, or retained?
3. What specific revisions should FDA make to the proposed rule's
principles or framework to better reflect our modernization goals of:
a. Protecting consumers against economic adulteration?
b. Ensuring standardized foods continue to meet consumer
expectations?
c. Maintaining the basic nature, essential characteristics, and
nutritional integrity of food?
d. Promoting industry innovation?
e. Providing flexibility to produce more healthful foods?
f. Facilitating additional flexibility across all or broad
categories of standardized foods?
4. How should FDA weigh the general principles?
a. The proposed rule stated that the first four principles were the
most fundamental to addressing consumer
[[Page 10110]]
economic protection and therefore, FDA would consider eliminating a
food standard if it is inconsistent with any of these four principles.
i. Please explain whether you agree with this framework.
ii. If you do not agree, what principles should FDA consider when
deciding whether to eliminate a food standard?
b. The proposed rule explained that FDA would consider revising or
establishing a new food standard only if it was consistent with all 13
principles.
i. Please explain whether you agree with this framework.
ii. If you do not agree, what principles should FDA consider when
deciding whether to revise or establish a new food standard?
5. What explanation is needed to provide more clarity, certainty,
or context regarding:
a. The rationale for the principles?
b. How FDA will consider the principles when evaluating whether to
eliminate, revise, or establish a new food standard?
c. How stakeholders should use the principles to inform the
preparation of petitions requesting that FDA eliminate, revise, or
establish a new food standard?
6. What additional information should FDA consider when evaluating
the costs, benefits, and estimates of the annual reporting burden of
the proposed rule?
Dated: February 13, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-03437 Filed 2-20-20; 8:45 am]
BILLING CODE 4164-01-P